| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |